Given the role of TFP in CL metabolism and the abnormalities in CL quantity and pattern observed in TFP‐LCHAD deficiency, elamipretide is a logical therapeutic candidate [23]. Here, HADHA is linked to hyperinsulinemic hypoglycemia, familial, 4.